Impulse Dynamics USA Inc

Impulse Dynamics USA Inc manufactures the Optimizer® Smart Mini system, a minimally invasive implantable cardiac device that delivers Cardiac Contractility Modulation (CCM®) therapy for patients with moderate to severe chronic heart failure. The device is indicated for NYHA Class III heart failure patients with LVEF 25–45% who remain symptomatic despite guideline-directed medical therapy and are not candidates for cardiac resynchronization therapy (CRT). The Optimizer® Smart Mini senses cardiac electrical activity and delivers precisely timed, non-excitatory electrical pulses throughout the day to improve functional capacity, exercise tolerance, quality of life, and 6-minute walk distance. The system has no pacemaker or ICD functions. As of the company's reporting, the device has been implanted in over 9,000 patients. Medicare National Coverage Determination (NCD) was issued for CCM® therapy, covering all FDA-indicated patients age 18 and older who have not undergone heart transplant. The company provides physician finder and patient education resources to support treatment access. Impulse Dynamics serves the global heart failure market, targeting the growing patient population (64+ million adults worldwide; 5.7 million in the US, projected to exceed 8 million by 2030).